|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 9/50 | |||
| A61K 47/48 | |||
| A61K 31/357 |
| (11) | Patento numeris | 2394643 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11179776.7 |
| Europos patento paraiškos padavimo data | 2007-11-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-09-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 859502 P | 2006-11-17 | US |
| (72) |
Bhatt, Padmanabh P., US
Liang, Likan, US
Vieira, Michael L., US
Wang, Hua, US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | Sustained-release formulations of topiramate |
| Sustained-release formulations of topiramate |